Insight Molecular Diagnostics Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q1 18 | Q2 18 | Q3 18 | Q1 19 | Q2 19 | Q3 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,081.3% | 255.2% | 108.3% | 142.3% | 93.0% | 119.4% | 188.0% | 35.0% | 86.9% | 501.5% | 96.6% | 41.3% | 42.2% | 74.4% | 51.9% | 56.5% | 60.0% | 38.0% | 32.4% | 46.5% | 56.5% | 1,992.2% | 34.3% | 88.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -981.3% | -155.2% | -8.3% | -42.3% | 7.0% | -19.4% | -88.0% | 65.0% | 13.1% | -401.5% | 3.4% | 58.7% | 57.8% | 25.6% | 48.1% | 43.5% | 40.0% | 62.0% | 67.6% | 53.5% | 43.5% | -1,892.2% | 65.7% | 11.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13,493.8% | 2,255.2% | 471.2% | 357.9% | 299.0% | 125.0% | 319.3% | 528.2% | 1,031.2% | 2,197.0% | 716.2% | 525.9% | 509.3% | 1,313.6% | 2,358.7% | 2,449.6% | 151.9% | 136.8% | 633.4% | 1,491.5% | 511.8% | 14,375.0% | 1,877.0% | 1,125.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 28,906.3% | 2,628.7% | 900.0% | 677.9% | 423.8% | 388.5% | 818.1% | 1,554.7% | 2,297.9% | 8,277.6% | 1,368.0% | 815.1% | 724.0% | 1,918.2% | 2,314.4% | 2,230.4% | 212.7% | 145.7% | 511.0% | 978.8% | 350.9% | 9,346.9% | 1,202.1% | 742.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 51,712.5% | 5,976.2% | 1,116.8% | 1,203.6% | 1,017.7% | 649.0% | 1,294.5% | 858.9% | 699.2% | 2,144.8% | -1,966.3% | 1,850.1% | 1,576.0% | 5,290.9% | 4,501.9% | 11,795.7% | 2,303.0% | 380.0% | 1,967.6% | 4,302.7% | 917.1% | 30,392.2% | 4,836.4% | 2,569.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -52,693.8% | -6,131.5% | -1,125.0% | -1,245.9% | -1,010.7% | -668.4% | -1,382.5% | -793.9% | -686.1% | -2,546.3% | 1,969.7% | -1,791.4% | -1,518.2% | -5,265.3% | -4,453.8% | -11,752.2% | -2,262.9% | -318.0% | -1,900.0% | -4,249.2% | -873.6% | -32,284.4% | -4,770.7% | -2,558.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 137.5% | 52.4% | 14.1% | 15.3% | 6.0% | 2.4% | 5.1% | 7.9% | 8.9% | 20.9% | 3.7% | 3.0% | 3.3% | 8.5% | 7.7% | 27.0% | 2.0% | 1.4% | 4.8% | 11.2% | 2.3% | 71.9% | 8.4% | 5.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -55,168.8% | -6,369.2% | -1,222.2% | -1,285.9% | -1,021.6% | -605.3% | -1,402.4% | -898.2% | -575.5% | -2,713.4% | 2,006.4% | -1,799.8% | -1,512.6% | -5,186.9% | -4,355.8% | -11,733.0% | -2,255.1% | -312.0% | -1,880.7% | -4,174.6% | -2,015.4% | -13,406.3% | -4,711.3% | -2,955.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -6,843.8% | 41.3% | -526.5% | -31.6% | -673.0% | -88.4% | 4.3% | 25.5% | -110.5% | 167.2% | 985.2% | 1,060.7% | 214.9% | 4,971.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -48,325.0% | -6,369.2% | -1,222.2% | -1,254.3% | -348.7% | -516.9% | -1,402.4% | -2,708.2% | -3,502.1% | -13,929.9% | 1,021.2% | -1,799.8% | -1,512.6% | -5,186.9% | -4,355.8% | -11,733.0% | -2,255.1% | -312.0% | -1,880.7% | -4,174.6% | -2,015.4% | -13,406.3% | -4,711.3% | -2,955.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -53,612.5% | -6,150.3% | -1,013.2% | -1,380.9% | -977.5% | -539.8% | -1,270.8% | -570.5% | -2,743.0% | -8,840.3% | 2,169.0% | -1,698.1% | -1,410.0% | -4,988.1% | -4,034.6% | -11,410.4% | -2,215.2% | -287.7% | -1,768.0% | -3,938.8% | -1,963.7% | -11,362.5% | -4,424.7% | -2,803.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.